Activating endogenous immune mechanisms to eliminate senescent cells.

Deciduous Therapeutics is pioneering a novel immunotherapy approach to target and eliminate senescent cells, which accumulate in age and different disease conditions. Their platform addresses the limitations of current treatments by activating endogenous immune surveillance mechanisms to selectively remove senescent cells and minimizing their metabolic and fibrotic impact.